Abstract

CRISPR-Cas9 has revolutionized the field of genetic engineering, offering unprecedented precision and efficiency in gene editing. This technology, derived from a bacterial immune system, allows for targeted modifications to the DNA of living organisms, including humans. While the scientific potential of CRISPR-Cas9 is vast, ranging from curing genetic diseases to improving agricultural yields, it also raises significant ethical concerns. This article explores the scientific mechanisms of CRISPR-Cas9, its applications, and the ethical dilemmas it poses. We also discuss the regulatory landscape and future directions for this transformative technology.